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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Using gradient ionic detergent, we optimized the preparation procedure
for the decellularized liver biologic scaffold, and analyzed its immunogenicity and
biocompatibility.
Methods: EDTA, hypotonic alkaline solution, Triton X-100, and gradient sodium dodecyl sulfate
(1%, 0.5%, and 0.1%, respectively) were prepared for continuous perfusion through the hepatic
vascular system. The decellularization of the liver tissue was performed with the optimized re-
agent buffer and washing protocol. In addition, the preservation of the original extracellular ma-
trix was observed. To analyze its biocompatibility, the scaffold was embedded in a heterologous
animal and the inflammation features, including the surrounding cell infiltration and changes of
the scaffold architecture, were detected. The cell-attachment ability was also validated by the
perfusion culture of HepG2 cells with the scaffold.
Results: By using gradient ionic detergent, we completed the decellularization process in approx-
imately 5 h, which was shorter than>10 hours in previous experiments (p< 0.001). The extracel-
lular matrix was kept relatively intact, with no obvious inflammatory cellular infiltration or
structural damage in the grafted tissue. The engraftment efficiencies of HepG2 were 86 5%
(nZ 8). The levels of albumin and urea synthesis were significantly superior to the ones in tradi-
tional two-dimensional culture.
Conclusion: The current new method can be used efficiently for the decellularization of the liver
biologic scaffold with satisfying biocomparability for application both in vivo and in vitro.
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Liver tissue engineering 681IntroductionPreparation of intact three-dimensional scaffolds by
decellularization is a significant breakthrough in biological
scaffold preparation,1 that has been proven possible in a
variety of tissues and organs.2e7 This approach has also
shown great progress in liver tissue engineering.8e13 There
has been no standard protocol for the preparation of
decellularized bioscaffolds, and a current topic of debate is
which detergent has any obvious advantage in their
preparation.14,15
The goal of this study was to completely elute cellular
components using the method that is most gentle, which
was achieved by emphasizing and further defining sodium
dodecyl sulfate (SDS) concentrations. From the use of a
single concentration in earlier studies to the establishment
of a gradient, we managed to maintain the efficacy of
decellularization using ionic detergents at the minimum
dose and the lowest concentration. At the same time, we
analyzed the decellularization efficiency by assessing
perfusion through different routes according to the
anatomical structure of the hepatic canalicular system.
One reason for developing a decellularization technique
is to achieve the transmission of tissues and organs across
species; for example, the adaptation of decellularized
tissues and organs from large animals for use in humans.
The theoretical basis of this application is that the extra-
cellular matrix components are of low immunogenicity
between species. Currently, the research into whole-liver
bioscaffolds focuses on the preparation of whole-liver
scaffolds, recellularization of the scaffold tissues, and
monitoring of transplantation among homogeneous spe-
cies.8 There has been no report on rejection responses
against decellularized liver tissues in heterologous ani-
mals. In the current study, by preparing decellularized
liver tissues and embedding them in the muscle tissues of
heterologous animals, inflammatory infiltration and struc-
tural preservation were monitored. The potential
biocompatibility of the decellularized liver tissue was
verified.Materials and methods
Experimental animals and reagents
Forty specific pathogen-free (SPF) male or female Sprague-
Dawley (SD) rats, weighing 200e300 g, and 20 New Zealand
white rabbits, weighing 1.9e2.5 kg, were purchased from
the Experimental Animal Center of the Southern Medical
University [Certification: SCXK (Guangdong) 20060015].
Animal use during the study followed "The Guidance for the
Treatment of Laboratory Animals" published by the Ministry
of Science and Technology in 2006.
HepG2 cells, a human liver carcinoma cell line,16 were a
gift from the Guangzhou Institute of the Chinese Academy
of Science. Tris-HCl buffer was prepared and used as a
solvent to prepare 1% Triton X-100 (Sigma-Aldrich, St.
Louis, MO, USA) and SDS (1%, 0.5%, and 0.1%). D-Hanks
medium was prepared and used to prepare EDTA (Sigma-
Aldrich).The isolation of liver from SD rats
SD rats (nZ 10) were anesthetized by intraperitoneal in-
jection of chloral hydrate, followed by topical skin disin-
fection. A transverse incision was made in the abdomen,
which exposed the portal vein, the bile duct, and the
inferior vena cava. A total of 2 mL heparin sodium was
injected for anticoagulation. The branches of the portal
vein were ligated. The portal vein was then cut with a side
hole for intubation and double-fixed with number 1 silk
sutures. The hepatic superior and inferior vena cava were
isolated and both were cut with a side hole for intubation.
The inferior vena cava was then transected and the whole
liver was isolated.
Liver decellularization by different routes
First, the portal vein was perfused with D-Hanks medium
containing 0.02% EDTA and then with 1% Triton X-100 for
approximately 1 hour. After rinsing with 500 mL phosphate
buffered saline (PBS), the liver was perfused sequentially
with 500 mL 1%, 0.5%, and 0.1% SDS, followed by a wash
with PBS. The perfusion rate for each step was 10 mL/min.
Additional fresh liver samples (nZ 10) were perfused
through the inferior vena cava in the same order as
mentioned previously. The prepared biological scaffolds
were preserved in PBS at 4C.
Analyzing ECM components of the whole-liver
bioscaffolds
The samples were randomly collected from scaffolds, and
the tissue sections were analyzed with hematoxylin and
eosin (H&E) and Masson trichrome staining. Scanning elec-
tron microscopy (SEM) was used to observe the micro-
structure of the ECM.
The samples were collected from decellularized bio-
scaffolds and fresh liver and embedded, sectioned, dehy-
drated with gradient ethanol, and then incubated with
1:100 diluted primary rabbit antirat fibronectin or rabbit
antirat laminin antibodies (Boster Biological Technology
Ltd., Wuhan, China). This step was followed by the addition
of secondary biotinylated goat antirabbit antibodies (Boster
Biological Technology Ltd.) and visualization with dia-
minobenzidine. The ECM components were analyzed by
Western blot analysis with the indicated primary anti-
bodies, including anticollagen I, anticollagen III, anti-
fibronectin, and antilaminin (Boster Biological Technology
Ltd.), and horseradish peroxidase-conjugated secondary
antibodies. The dilution ratio of the antibodies used was
based on the manufacturer’s recommendations.
Analyzing the vascular system of the whole-liver
bioscaffolds
The 8e10% filler (containing red dye) was prepared in
perchloroethylene and acetone and was slowly infused into
the portal vein or the inferior vena cava. The preservation
of the vascular structure of the whole-liver bioscaffolds was
observed, and the local leakage of casting agents was
monitored.
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bioscaffolds in heterologous animals
The samples were collected randomly from the whole
scaffolds, and the tissue blocks were incubated in 0.1%
peracetic acid at 37C for 3 hours on a shaker at 300 rpm.
Then, the tissue blocks were washed with PBS for 15 mi-
nutes with shaking at 300 rpm. A 2-cm incision was made on
the back of New Zealand white rabbits (nZ 20), and a
tissue block approximately 1 cm in diameter and 3 mm in
thickness was embedded in the back muscles (the size of
samples was based on BS/EN/ISO standards). The surgical
procedure was performed in sterile conditions, and the
dressings were changed every day after surgery. Addition-
ally, 80,000 units of penicillin were applied for 3 consecu-
tive days after suture, once in the morning and once in the
evening. The control group (nZ 20) was from the same
batch, had the same body weight, and was notched on the
back as a sham surgery. The condition of eating and
drinking was monitored daily, and blood samples were
collected daily for assessment of C-reactive protein (CRP)
and immunoglobulin E (IgE; Table 1).Biocompatibility evaluation with HepG2 culture
To simulate the environment in vivo, we constructed a
circulation perfusion culture device loaded with the
decellularized liver scaffold, including a peristaltic pump,
bubble remover, oxygenator. The portal venous structure
was connected with the circulation and was the medium
inlet, with a patent hepatic vein. HepG2 cells were seeded
using the method by Uygun et al,8 and a total of
100 106 cells were injected into the scaffold via the
portal vein in four steps, with 15-minute intervals between
each step. The perfusion culture was carried out at a rate
of 5 mL/min. The temperature was 37C, and continuous
ventilation was maintained with 95% oxygen and 5% carbon
dioxide. The medium was changed every 2 days. The
engraftment rate was calculated from the total number of
implanted cells minus the number of cells floating in the
medium.Statistical analyses
Statistical analysis was carried out using SPSS version 13.0
(SPSS Inc. Chicago, IL, USA). Results were expressed as
mean standard deviation (SD). Statistical differences of
cell functions between perfusion culture and two-Table 1 Comparison of C-reactive protein and immuno-
globulin E after transplantation of scaffold.
Surgery group
(nZ 20)
Control group
(mg/L) (nZ 20)
p
CRP (mg/L) 0.12 0.03 0.14 0.05 0.1672
IgE (IU/L) 4.1 0.4 3.6 0.6 0.9260
Data are presented as mean SD.
CRPZ C-reactive protein; IgEZ immunoglobulin E.dimensional culture were evaluated by Student t test.
A p value< 0.05 was considered statistically significant.Results
The decellularization process of liver organ
By using a decellularization perfusion device, it could be
seen that the liver color gradually changed, from the blood
flushing out of the liver (Fig. 1A), to the liver turning
yellowish-brown, and ending in transparency (Fig. 1B). The
entire process took approximately 5 hours. Through the
capsule of the prepared whole-liver scaffold, the Glisson
system, portal vein, and the biliary tract could be seen.Liver decellularization with different routes
The bioscaffolds prepared from perfusion through the por-
tal vein or the inferior vena cava showed the same decel-
lularized efficiency (Fig. 1DeF). It cost less perfusion
gradient during perfusion (mean, 4100 mL vs. 7000 mL,
p< 0.001), and the time for perfusion to transparency was
significantly shorter than our previous procedure and that
of Uygun et al8 (mean, 5 hours vs. 12 hours and 5 hours vs.
52 hours, p< 0.001).17The ECM components of whole-liver bioscaffolds
were well preserved
Comparison of H&E-stained normal livers (Fig. 2A) and
decellularized whole-liver bioscaffolds (Fig. 2B) showed no
residual cells in the decellularized samples. From the
comparative analysis of Masson trichrome staining (Fig. 2C
and D), most of the collagen fiber components of the ECM
were retained and the collagen fibers maintained tubular
structures. Under SEM, residual cells were also not found
(Fig. 2J), and the major (Fig. 2L) and minor vascular
branches (Fig. 2K) were observed in the bioscaffolds.
Immunohistochemical analysis indicated the presence of
fibronectin and laminin in the bioscaffolds (Fig. 2F and H)
when compared to these two ECM components from fresh
liver (Fig. 2E and G). The results from Western blot ana-
lyses showed the preservation of collagen I, collagen III,
fibronectin, and laminin in the decellularized bioscaffolds
(Fig. 2I). According to the experimental data, there were
no significant differences between the experimental and
control groups.The vascular system in the whole-liver bioscaffolds
was well preserved
As shown in Fig. 3, by slowly infusing with red casting agent
through the portal vein, the main branch of the vascular
system was seen first. With the advancement of the casting
agent, the microvascular structures were gradually
revealed. There was no leakage of casting agents through
the vascular walls, suggesting that the decellularization
procedure did not cause damage to the vascular structure.
Figure 1 (A) Fresh rat liver. (B) Decellularized scaffold. (C) Perfusion device diagram in decellularization. (DeF) Macroscopy of
the liver at decellularization, 5 minutes (D), 2 hours (E) and 5 hours (F).
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compatibility in heterologous animals
After surgery, the animals showed normal behavior in re-
gard to eating and drinking. The blood samples were
collected for 7 days to determine the level of CRP and IgE.
Compared to the control group, there was no significant
difference in CRP (mean, 0.12 0.03 mg/L vs.
0.14 0.05 mg/L, tZ 1.414, pZ 0.1672) and IgE (mean,
4.1 0.4 k IU/L vs. 3.6 0.6 k IU/L, tZ 1.0, pZ 0.926). At
2 weeks (nZ 10) and 4 weeks (nZ 10) after embedding,
the implanted tissue samples were harvested. The decel-
lularized rat liver tissues appeared white and softer in
texture. H&E staining of tissue sections is shown in Fig. 4A
and C. Additionally, Wright staining of the tissue samples
was performed at 2 weeks and 4 weeks of embedment. AsFigure 2 (AeH) Histologic comparison of normal liver (A,C,E,G) a
staining (AeB); Masson trichrome staining (CeD); immunohistochem
blot showed the expression of collagen I, collagen II, fibronectin, a
Extracellular matrix showed invisible cells in decellularized matrix
vasculature (L). Magnification: AeF 100; GeH 200; J and K 3000shown in Fig. 4B and D, infiltrated inflammatory cells were
still present at the conjunction of the implanted liver tis-
sues and the back muscle tissues at 2 weeks of embedment.
Nevertheless, the border between the experimental sam-
ples and the muscle tissues was well defined at 4 weeks of
embedment, with no obvious infiltration. Meanwhile, Mas-
son trichrome staining (Fig. 4E and F) showed the extensive
presence of collagen fibers, revealing no apparent struc-
tural changes.
Function of HepaG2 cultured within the
decellularized scaffold
A total of eight perfusion culture experiments were carried
out to implant HepG2 cells. The average engraftment effi-
ciency was 86 5%. We measured albumin and urea levelsnd decellularized liver matrix (B,D,F,H): hematoxylin and eosin
istry staining of fibronectin (EeF) and laminin (GeH). Western
nd laminin, which was compatible with normal liver (I). (JeL)
(J), matrix retains an intact tiny lobular structure (K) and main
; L 1200.
Figure 3 Cast model of one liver lobe demonstrates the integrity of (A) the hepatic vein and (B) the portal vein.
684 M.X. Pan et al.to evaluate the function of cells in the scaffold and the
results showed that the 7-day cumulative albumin synthesis
and urea secretion in HepG2 cells after perfusion culture
were significantly higher than that after two-dimensional
culture (albumin synthesis, 27.5 1.7 mg/106 cells vs.
19.0 1.4 mg/106 cells, p< 0.001; urea secretion,
14.5 2.5 mmol/106 cells vs. 12.7 1.1 mmol/106 cells,
p< 0.05) (Fig. 5A and B). On Day 5 of culture, HepG2 cells
were distributed throughout the scaffold (Fig. 5C). TheFigure 4 (A and C) Histologic change after the embedding perform
and eosin staining. (C and D) Wright staining showed there were s
matrix, but with no obvious infiltration at 4 weeks. (E and F) Mass
preserved in the boundary (E) and center (F) of the implanted maresults showed that HepG2 perfusion culture is superior to
conventional two-dimensional culture.Discussion
Scaffold materials not only provide ample space for cellular
colonization, expansion, and proliferation, but they also
provide morphology control in two- and three-dimensionaled at 2 weeks and (B and D) at 4 weeks. (A and B) Hematoxylin
till some inflammatory cells at the boundary of the implanted
on trichrome staining showed the collagen fibers were largely
trix. Magnification: A, B, and E 100; C, D, and F 200.
Figure 5 Function of the recellularized liver graft in vitro. (A) Albumin synthesis and (B) urea secretion of HepG2 cells, in
comparison with static two-dimensional culture (p< 0.05 for albumin and urea, by Student t test). nZ 8.
Liver tissue engineering 685cell culture.18 In liver tissues, the ECM components not only
regulate cell adhesion, migration, differentiation, prolif-
eration, etc, but they also transmit signal transduction
between different cells.19 In the process of decellulariza-
tion, both the decellularization efficiency and the preser-
vation of the ECM need to be taken into account. This
requires the application of a detergent demonstrating
highly efficient elution and tissue-destructive activity.
Considering the combinational characteristics of the
liver (such as complicated structure, copious cells, and
abundant cellular enzymes) we chose continuous perfusion
with detergent containing EDTA, hypotonic alkaline solu-
tion, Triton X-100, and SDS for decellularization. EDTA
dissociated the junctions between the cells as well as the
cells and the ECM. TritonX-100 acted mildly, preventing a
sudden enzyme burst from the massive cell destruction,
which might have caused damage to the ECM. However, its
decellularization activity was not thorough and required an
adequate amount of SDS for enhancement. The currently
used approach for decellularization usually relies on a
higher dosage of ionic detergents to guarantee decellula-
rization. The advantage of our elution procedure was to
ensure decellularization efficiency with the use of a mini-
mum amount of ionic detergents critical to the integrity of
the ECM components and structures, yet finishing the
preparation of whole-liver bioscaffolds in the shortest
amount of time. In addition, the decreased dosage of SDS
could gradually diminish the residual of SDS in the scaffold;
meanwhile, it reduced the volume of PBS for rinsing out of
the ionic detergent. Therefore, we chose this modified
method rather than previous methods.
In regard to the different routes for perfusion, we found
that due to the smaller hepatic artery and bile duct of rats,a longer perfusion time tended to cause tube detachment
and the increased pressure could lead to bile duct
breakage. The portal vein had the advantages of suitable
vascular diameter, easy exposure, and not being easily
twisted after intubation. According to the analysis by
Baptista et al10 on perfusion via the portal vein system or
inferior vena cava system, the sites of concentration and
action of the eluting agent were different inside the he-
patic lobule. Therefore, different perfusion routes might
lead to different eluting efficiencies. In our study, both
perfusion routes (the portal vein and the inferior vena cava)
were investigated. Both showed similar elution effects and
took approximately 5 hours, the shortest time among cur-
rent studies in the same field.8,9 In addition, although these
two perfusion routes showed no differences, we could rule
out the possibility that combining forward and reverse
routes in large animals might increase perfusion efficiency.
The ECM components are usually produced and secreted
by resident cells in the tissues and organs, and they are
maintained in dynamic homeostasis with the surrounding
environment.20 Because the ECM is produced by the original
resident cells of each tissue and organ, it is theoretically an
ideal cell substrate.21e24 ECM is a complex composed of
multiple structural and functional molecules arranged in
tissue-specific and three-dimensional structural order.25e27
The ECM components, including collagens, are highly
conserved between species, and therefore do not usually
cause obvious immune responses.28,29
The decellularized liver bioscaffolds are completely free
of cellular components and theoretically will not induce
apparent immune rejection. However, it cannot be
completely ruled out that the different components of the
ECM between heterologous animals might induce the
686 M.X. Pan et al.production of heterologous antibodies. During the prepa-
ration of bioscaffolds, the completeness of decellulariza-
tion, the differences in ECM components, and the
complicated intrinsic environment of the recipients can
affect potential immunogenicity and inflammatory re-
sponses. To verify these factors, preliminary investigation
of the rejection response against the liver tissue scaffolds
in the heterologous animals was undertaken.
Following implantation of the decellularized liver bio-
scaffolds derived from SD rats into the back muscles of New
Zealand white rabbits, cellular infiltration and structural
destruction surrounding the embedded tissue blocks were
monitored at different time points. According to the he-
matological index, it was concluded that the decellularized
liver tissue did not induce apparent immune rejection in
the heterologous animals.
Since Uygun et al8 first reported successful culture of
hepatocytes in decellularized liver scaffold in 2010, more
studies have reported that the decellularized liver scaffold
is superior to the previous iteration. Our study provided a
safe and operational basis for the application of decellu-
larized rat liver bioscaffolds. Perfusion culture with HepG2
was rarely reported. The results showed that cells grew
well in the decellularized liver scaffold and revealed the
good biocompatibility between heterologous animals and
provided the possibility for tissue reengineering. However,
due to the complexity of the liver structure, more in-
vestigations are needed to address the major issues in this
area, such as the standardized protocols for the decellu-
larization of large animals, and the bioreactors design and
culture protocols for recellularization.Acknowledgments
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